The shareholders of
Participation at the AGM
Shareholders who wish to attend the AGM shall:
- be registered in the shareholders' register maintained by
- notify the Company of their attendance at the following address:
When registering, the shareholder must state their name, personal or organization number (or equivalent), address, telephone number (daytime), shareholding, information on any assistants, and, if applicable, information on proxies or representatives.
Nominee-Registered Shares
In addition to giving notice to participate, shareholders who have their shares nominee-registered through a bank or other nominee must request to be entered in the share register in their own name (a process known as voting rights registration). Such shareholders must re-register their shares in their own name so that the shareholder is registered in the share register maintained by
Proxy and Power of Attorney Forms
Shareholders represented by proxy must issue a dated power of attorney, or a future power of attorney for the proxy. Anyone representing a legal entity must present a certificate of registration (or an equivalent authorization document) showing that the persons who have signed the power of attorney are authorized signatories for the shareholder. The original power of attorney (with any authorization documents) should be sent to the Company at the address specified above well in advance of the annual general meeting. The power of attorney must not have been issued more than five years before the date of the meeting. A future power of attorney does not need to be sent in original but can be shown at the meeting. The Company provides power of attorney forms upon request, and this is also available on the Company’s website, www.savelendgroup.se.
Proposed Agenda
The Board's proposed agenda for the Annual General Meeting:
1. Opening of the meeting and election of a chairperson for the meeting
2. Preparation and approval of the voting list
3. Election of one or two adjusters
4. Verification of whether the meeting has been duly convened
5. Approval of the agenda
6. Presentation of the annual report and auditor's report as well as the consolidated financial statements and auditor's report for the group
7. Resolutions on:
a) adoption of the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet,
b) appropriation of the Company’s profit or loss according to the adopted balance sheet, and
c) discharge of liability for the board members and the CEO
8. Resolution on the number of board members and deputy board members
9. Resolution on the remuneration for the Board of Directors and the auditor
10. Election of board members and auditor
11. Resolution on authorization for the board to issue new shares, warrants, and/or convertibles
12. Resolution on the introduction of incentive program 2024/2027:I for senior executives and key employees by a) issuing warrants of series 2024/2027:I and b) approval of the transfer of warrants
13. Resolution on the introduction of incentive program 2024/2027:II for board members by a) issuing warrants of series 2024/2027:II and b) approval of the transfer of warrants
14. Decision on guidelines and instructions to the nomination committee
15. Conclusion of the meeting
Proposed Resolutions
Item 1 – Election of the Chairman for the Meeting
The Nomination Committee for the 2024 Annual General Meeting consisted of Per Wolf (appointed by
The Nomination Committee proposes that the Chairman of the Board, Bo Engström, be elected as the Chairman for the meeting.
Item 7 b) – Appropriation of the Company’s profit or loss according to the adopted balance sheet
The Board proposes that the Company's accumulated profit be carried forward to new account and that no dividend distribution takes place for the fiscal year 2023.
Items 8 - 10 – Resolution on the Number of Board Members and Deputy Board Members, Resolution on the remuneration for the Board and Auditor, and Election of Board and Auditor
The Nomination Committee proposes that the Board shall consist of 6 regular members with no deputies.
The Nomination Committee proposes that, like the previous year, the remuneration for the Board should be
The Nomination Committee proposes that the remuneration for the auditor be paid according to an approved invoice.
The Nomination Committee proposes that the meeting decides on the re-election of Bo Engström, Birgit Köster Hoffmann,
The Nomination Committee also proposes the re-election of
Item 11 – Resolution on authorization for the board to decide on new share issues, warrants, and/or convertibles
The Board proposes that the Annual General Meeting authorizes the Board, within the framework of the articles of association applicable when the Board first utilizes the authorization, on one or several occasions until the next annual general meeting, with or without preferential rights for the shareholders, to decide on the issuance of shares, warrants, and/or convertibles, resulting in the issuance or conversion to so many new shares that at the time of the first issuance decision according to this authorization corresponds to no more than 20 percent of the total share capital of the Company.
A deviation from the shareholders' preferential rights may occur in order to strengthen the Company's capital base, broaden the ownership of the Company, or otherwise strengthen the Company's financial position. Issuance in accordance with this authorization shall occur on market terms.
The Board, or anyone the Board appoints, shall have the right to make minor adjustments that may be necessary in connection with the registration of the decision with the Swedish Companies Registration Office.
For a valid decision according to the above, the support of shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting is required.
Item 12 – Resolution on the introduction of incentive program 2024/2027:I for senior executives and key employees by a) issuing warrants of series 2024/2027:I and b) approval of the transfer of warrants
The Board proposes that the Annual General Meeting decides to establish a warrant based incentive program through the issuance of warrants of series 2024/2027:I to the Company, or a subsidiary designated by the Company, and approves the transfer of warrants of series 2024/2027:I to senior executives and other key personnel in the Company or its subsidiaries (the "Group") under the following conditions.
The Board believes it is crucial and in the interest of all shareholders that the management and other key personnel, who are deemed important for the Company's further development, have a long-term interest in the good value development of the Company's shares. A personal long-term ownership engagement is expected to contribute to an increased interest in the Company's operations and profit development, as well as enhance the participants' motivation and affiliation with the Company and its shareholders.
a. issuance of warrants of series 2024/2027:I
The Board proposes that the Annual General Meeting decides on a directed issuance of no more than 1,380,238 warrants of series 2024/2027:I, entailing an increase in the share capital by no more than approximately
1. Number of warrants issued
The Company shall issue no more than 1,380,238 warrants of series 2024/2027:I. Each warrant entitles the holder to subscribe for one (1) new share in the Company.
2. Subscription Right
With deviation from the shareholders' preferential rights, the new warrants may only be subscribed for by the Company, or a subsidiary designated by the Company, with the right and obligation to transfer the warrants to senior executives and other key personnel in the Group in accordance with the proposal under item B below. The reason for the deviation from the shareholders' preferential rights is that the warrants are to be used for the implementation of the incentive program 2024/2027:I.
3. Issue Price
The warrants are to be issued at no charge to the Company, or a subsidiary designated by the Company.
4. Subscription Period
The warrants shall be subscribed for on a separate subscription list within two weeks from the decision on the issue. The Board shall have the right to extend the subscription period.
5. Exercise period of warrants
The warrants can be exercised by applying for the subscription of new shares from
6. Subscription price
The subscription price per share when exercising the warrants shall amount to 150 percent of the calculated average volume-weighted payment price for the Company's share on Nasdaq First North Growth Market during the period from
7. Increase in share capital
The increase in the Company's share capital, upon full exercise of the warrants, may amount to no more than approximately
Holders of the warrants shall have the right, when subscribing for shares by exercising the warrants, to request that an alternative redemption model be applied in accordance with the complete terms and conditions for the warrants. The alternative redemption model means that participants who so wish do not need to pay as high a cash amount when subscribing for shares with the support of the warrants but will instead receive a smaller number of shares. When applying the alternative redemption model, (i) the subscription price for each share shall correspond to the share's quotient value and (ii) the warrants shall entitle to a recalculated lower number of shares (subject to any adjustment in accordance with the complete terms and conditions for the warrants), meaning that the alternative redemption model can never result in increased dilution compared to if all the warrants were exercised for subscription of shares at the original subscription price. Assuming that the subscription price for subscribing for shares with the support of the warrants is set at
Illustrative calculation example of the alternative redemption model assuming a subscription price of
Share price | Total number of new shares | Total dilution |
230,040 | 0.43% | |
460,079 | 0.85% | |
690,119 | 1.27% |
8. Dividends
Shares subscribed for by exercising the warrants of series 2024/2027:I entitle the holder to dividends for the first time on the record date for dividend that occurs closest after the new shares have been registered and entered into the share register maintained by
b. approval of the transfer of warrants
The Board proposes that the Annual General Meeting decides to approve that the Company, or a subsidiary designated by the Company, within the framework of the incentive program 2024/2027:I, may transfer no more than 1,380,238 warrants of series 2024/2027:I to senior executives and other key personnel (“Participants”) in the Group, or otherwise dispose of the warrants to secure the commitments due to the incentive program 2024/2027:I, under the following conditions:
1. Participants and Allocation
The right to acquire warrants from the Company, or a subsidiary designated by the Company, shall be granted to the following categories of employees within the Group.
Category | Maximum Number of Warrants per Category | Maximum Number of Warrants per Person within the Category |
A: Senior Executives (Maximum 11 persons) | 1,104,191 | 200,000 |
B: Other Key Personnel (Maximum 20 persons) | 276,048 | 30,000 |
Participants may choose to subscribe for a lower number of warrants than specified above. If subscriptions are made to such an extent that the total number of warrants that can be issued within each category is oversubscribed, allocation shall be made pro rata to the number of warrants the Participant has indicated they wish to acquire. If warrants within a certain category remain after all applications within the category have been satisfied, the remaining number may be allocated to Participants in the same or another category, whereupon the board shall decide the distribution based on, among other things, category membership, personnel category, and the number of warrants applied for. However, such distribution may not result in exceeding the maximum number of warrants per person within a certain category as specified in the table above. The company's board decides on the final allocation.
The right to acquire warrants shall only be granted to those who, at the end of the application period, have not resigned or been terminated.
Transfer to Participants requires that the acquisition of the warrants can legally occur, and that, in the board's assessment, it can be done with reasonable administrative and economic efforts.
Warrants held by the Company, or a subsidiary designated by the Company, that have not been transferred according to this section B.1 or which are later repurchased from Participants, may either be reoffered to employees within the Company or its subsidiaries or cancelled by the Company upon a decision by the Company's board. Cancellation shall be reported to the
2. Price and Payment
The warrants shall be transferred at market conditions to a price (premium) that corresponds to a calculated market value of the warrants using a generally accepted valuation model calculated by an independent valuation institution. Such valuation shall be conducted according to accepted practices for option valuation. For acquisitions made by new employees after the end of the initial subscription period, a new market price shall be determined in a similar manner.
Payment for allocated warrants shall be made in cash no later than ten banking days after notification of acquisition. For transfers to new employees, the board shall determine a corresponding payment date. The warrants shall otherwise be subject to market conditions.
3. Pre-emptive Rights and Termination of Employment
A condition for being allocated warrants is that the Participant has signed a specific warrant agreement with the Company. The warrant agreement entails, among other things, that the warrants shall be subject to an obligation for Participants wishing to transfer or otherwise dispose of the warrants to a third party to first offer the Company or its subsidiary to acquire the warrants. The warrants shall also be subject to a right for the Company or its subsidiary to repurchase the warrants if a Participant's employment with or assignment for the Company ceases during the program's duration.
The Board, or whomever the Board appoints, shall be authorized to make minor changes to the decision that may be required for registration with the
For a decision in accordance with the Board's proposal as per this proposal, the decision must be supported by shareholders representing at least nine-tenths of both the votes cast and the shares represented at the Annual General Meeting.
Item 13 – Resolution on the introduction of incentive program 2024/2027:II for board members by a) issuing warrants of series 2024/2027:II and b) approval of the transfer of warrants
The shareholder
The shareholder assesses that it is essential and in the interest of all shareholders that the Board members, who are deemed important for the Company's further development, have a long-term interest in the good value development of the Company's stock. A personal long-term ownership engagement is expected to contribute to an increased interest in the Company's operations and profit development as a whole, as well as to enhance the motivation of the participants and result in an increased community of interest with the Company and its owners.
a. issuance of warrants of series 2024/2027:II
The shareholder proposes that the Annual General Meeting decides on a directed issuance of no more than 276,048 warrants of series 2024/2027:II, implying an increase in share capital of no more than approximately
1. Number of warrants issued
The Company shall issue no more than 276,048 warrants of series 2024/2027:II. Each warrant entitles the holder to subscribe for one (1) new share in the Company.
2. Subscription Right
With deviation from the shareholders' preferential rights, the new warrants may only be subscribed for by the Company, or a subsidiary designated by the Company, with the right and obligation to transfer the warrants to the board members of the Company elected by the 2024 Annual General Meeting, in accordance with what is stated in the proposal under item B below. The reason for the deviation from the shareholders' preferential rights is that the Company wishes to promote the Company's long-term interests by providing the Company's board members with a well-considered incentive program that allows them to share in a positive value development in the Company.
3. Issue Price
The warrants shall be issued free of charge to the Company, or a subsidiary designated by the Company.
4. Subscription Period
The warrants shall be subscribed for on a separate subscription list within two weeks from the decision of the issue. The Board shall have the right to extend the subscription period.
5. Exercise Period of warrants
The warrants can be exercised by applying for the subscription of new shares during the period from
6. Subscription Price
The subscription price per share when exercising the warrants shall amount to 150 percent of the calculated average volume-weighted payment price for the Company's share on Nasdaq First North Growth Market during the period from
7. Increase in Share Capital
The increase in the Company's share capital, upon full exercise of the warrants, may amount to no more than approximately
Holders of the warrants shall have the right, when subscribing for shares by exercising the warrants, to request that an alternative redemption model be applied in accordance with the complete terms and conditions for the warrants. The alternative redemption model means that participants who so wish do not need to pay as high a cash amount when subscribing for shares with the support of the warrants but will instead receive a smaller number of shares. When applying the alternative redemption model, (i) the subscription price for each share shall correspond to the share's quotient value, and (ii) the warrants shall entitle to a recalculated lower number of shares (subject to any adjustment in accordance with the complete terms and conditions for the warrants), meaning that the alternative redemption model can never result in increased dilution compared to if all the warrants were exercised for subscription of shares at the original subscription price. Assuming that the subscription price for subscribing for shares with the support of the warrants is set at
Illustrative calculation example of the alternative redemption model assuming a subscription price of
Share price | Total number of new shares | Total dilution |
46,008 | 0.09% | |
92,016 | 0.17% | |
138,024 | 0.26% |
8. Dividends
Shares subscribed for by utilizing the warrants of series 2024/2027:II entitle to dividends for the first time on the dividend record date that occurs closest after the new shares have been registered and entered into the share register maintained by
b) approval of transfer of warrants
The shareholder proposes that the Annual General Meeting decides to approve that the Company, or a subsidiary designated by the Company, within the framework of the incentive program 2024/2027:II, may transfer no more than 276,048 warrants of series 2024/2027:II to the board members of the Company elected at the 2024 Annual General Meeting, or otherwise dispose of the warrants to ensure the commitments under the incentive program 2024/2027:II, under the following conditions:
1. Allocation
The board members of the Company elected at the 2024 Annual General Meeting will, within the framework of the incentive program 2024/2027:II, be offered a total of no more than 276,048 warrants, where each member will be offered no more than 50,000 warrants.
Participants may choose to subscribe for a lower number of warrants than specified above. If the total number of warrants that participants wish to acquire exceeds the maximum number of warrants that can be issued according to the incentive program 2024/2027:II, a proportional reduction will be made in the number of warrants that each person can be allocated according to the guidelines above. Guaranteed allocation will not occur. A participant has the right to subscribe for a larger number of warrants than stated according to the guidelines above and may be allocated additional warrants if full subscription in the program has not occurred. In the event of such oversubscription, allocation will be made to those participants wishing to subscribe for additional warrants, pro rata in relation to the number of warrants they have been allocated in the first allocation.
Transfer to participants requires that the acquisition of the warrants can legally occur, and according to the Shareholder's assessment, can be carried out with reasonable administrative and economic efforts.
2. Price and Payment
The warrants shall be transferred at market conditions at a price (premium) that corresponds to a calculated market value of the warrants using a generally accepted valuation model calculated by an independent valuation institution. Such valuation shall be conducted according to accepted practices for option valuation.
Payment for allocated warrants shall be made in cash no later than ten banking days after notification of acquisition. The warrants shall otherwise be subject to market conditions.
3. Pre-emptive Rights and Termination of Assignment
A condition for being allocated warrants is that the participant has signed a specific option agreement with the Company. The option agreement entails, among other things, that the warrants shall be subject to an obligation for participants who wish to transfer or otherwise dispose of the warrants to a third party to first offer the Company or its subsidiary to acquire the warrants. The warrants shall also be subject to a right for the Company or its subsidiary to repurchase the warrants if a participant's assignment for the Company terminates during the program's duration.
The Board, or whom the Board appoints, shall be authorized to make minor changes to the decision that may be required for registration with the
For a decision in accordance with the Shareholder's proposal as per this proposal, the decision must be supported by shareholders representing at least nine-tenths of both the votes cast and the shares represented at the Annual General Meeting.
Item 14 – Decision on Guidelines and Instructions for the Nomination Committee
The Nomination Committee proposes that the general meeting resolves to establish the following principles for the appointment and instructions regarding the Nomination Committee (applicable until the general meeting decides otherwise).
The general meeting instructs the chairman of the board to contact the four largest shareholders or owner groups (hereby including both directly registered shareholders and nominee registered shareholders) in the Company, according to the printout from
If significant changes occur in the ownership after the last banking day in September, the Nomination Committee may, if it finds it necessary, decide to offer a new owner a place in the Nomination Committee in accordance with the principles above. Changes in the composition of the Nomination Committee shall be published on the Company's website. The Nomination Committee appoints the chairman of the Nomination Committee. No compensation shall be paid to the members of the Nomination Committee, but the Company shall pay any necessary expenses that the Nomination Committee may incur in the course of its work. The mandate period for the Nomination Committee ends when the subsequent Nomination Committee has been announced. At least three members must be present for decisions to be made. A proposal can be decided by a simple majority, and in the event of a tie, the casting vote shall be given to the member with the highest number of shares.
The task of the Nomination Committee is to present proposals to the annual general meeting for a) the chairman of the annual general meeting, b) board remuneration and other compensation for committee work, c) election of board members, d) election of the chairman of the board, e) election of auditor and auditor remuneration, and f) changes in the principles for the appointment and instruction of the Nomination Committee.
Disclosures at the Annual General Meeting
The board of directors and the CEO shall, if a shareholder requests it and the board believes that it can be done without significant harm to the Company, provide information about circumstances that can affect the assessment of an item on the agenda, conditions that can affect the assessment of the Company's or its subsidiaries' financial situation, or the Company's relationship to another group company. Those who wish to submit questions in advance can do so to:
Other
The annual report, audit report, proxy form, and complete proposals for decisions and other documents to be addressed at the annual general meeting will be available at the Company's office, address as above, no later than three weeks before the meeting. From the said date, the aforementioned documents will also be available on the Company's website, www.savelendgroup.se. Copies of said documents will also be sent free of charge to the shareholders who request it and thereby provide their postal address. The documents will also be available at the annual general meeting.
For information on how your personal data is processed, please refer to the privacy policy available on
http://www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf.
__________
The Board
© Modular Finance, source